A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/00 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2542412
Described is the use of xenon for preventing or reducing cellular death, preferably aberrant apoptosis. Preferred embodiments relate to the use of xenon for preventing (a) cellular damage for tissue and organs to be transplanted, (b) apoptotic cell death after eye laser surgery, and (c) for protecting endothelial cells of the intestine in sepsis.
Cette invention concerne l'emploi du xénon pour prévenir ou réduire la mort des cellules, de préférence en cas d'apoptose aberrante. Dans des modes de réalisation préférés, on utilise le xénon pour (a) prévenir des dégâts cellulaires dans le cas de tissus ou d'organes à transplanter, (b) prévenir la mort apoptotique de cellule après chirurgie oculaire au laser, et (c) protéger les cellules endothéliales des intestins en cas de sepsis.
Kox Wolfgang Johannes
Petzelt Christian Peter
Aga Ab
Air Products And Chemicals Inc.
Smart & Biggar
LandOfFree
Use of xenon for the prevention of programmed cell death does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of xenon for the prevention of programmed cell death, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of xenon for the prevention of programmed cell death will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1467266